Methods and kits for removing calculus from a tooth. The method includes applying a component A comprising hydrogen peroxide or a precursor thereto to the tooth; applying a component B comprising a catalase to the tooth, thereby generating oxygen; and removing at least a part of the calculus from the tooth; wherein the component A is applied before or after the component B is applied.

Methods and kits for removing calculus from a tooth. The method includes applying a component A comprising hydrogen peroxide or a precursor thereto to the tooth; applying a component B comprising a catalase to the tooth, thereby generating oxygen; and removing at least a part of the calculus from the tooth; wherein the component A is applied before or after the component B is applied.

This invention relates to oral care compositions comprising a first source of stannous, a second source of stannous, wherein the second source of stannous contains stannous pyrophosphate, and a zinc source selected from the group consisting of: zinc oxide, zinc citrate, zinc lactate, and combinations thereof, as well as to methods of using and of making these compositions.

This invention relates to oral care compositions comprising a first source of stannous, a second source of stannous, wherein the second source of stannous contains stannous pyrophosphate, and a zinc source selected from the group consisting of: zinc oxide, zinc citrate, zinc lactate, and combinations thereof, as well as to methods of using and of making these compositions.

The present invention relates generally to peroxyformic acid forming compositions, methods for forming peroxyformic acid, preferably in situ, using the peroxyformic acid forming compositions. The present invention also relates to the peroxyformic acid formed by the above compositions and methods. The present invention further relates to the uses of the peroxyformic acid, preferably in situ, for treating a surface or a target. The present invention further relates to methods for treating a biofilm using peroxyformic acid, including peroxyformic acid generated in situ.

The present invention relates generally to peroxyformic acid forming compositions, methods for forming peroxyformic acid, preferably in situ, using the peroxyformic acid forming compositions. The present invention also relates to the peroxyformic acid formed by the above compositions and methods. The present invention further relates to the uses of the peroxyformic acid, preferably in situ, for treating a surface or a target. The present invention further relates to methods for treating a biofilm using peroxyformic acid, including peroxyformic acid generated in situ.

A one step hair color and relaxer system comprising: an alkalizing agent in the range between about 0.1% to about 8%, based upon the total concentration of the hair color and relaxer system; a hair dye; and an oxidizing agent in the range between about 0.1% to about 6%, based upon the total concentration of the hair color and relaxer system; wherein the pH of the hair color and relaxer system is in the range between about 9 to about 14.

The invention relates to the use of a hydroperoxy alcohol-type compound, or a 1,2,4-trioxane compound thereof, as an antimicrobial agent, making it possible for it to be used in various applications and in particular as a preservative and/or to improve the antimicrobial properties of at least one preservative, to modulate the skin microbiota, in the treatment or prevention of diseases affecting the skin, the mucous membrane and/or skin appendages or even to cleanse, sanitise, disinfect and/or sterilise a surface other than the skin, skin appendages and mucous membranes, in particular a hard surface or a textile. It also relates to a composition comprising such a compound. In addition to its antimicrobial properties, the aforementioned compound has good safety and emollient properties, making it particularly suitable for cosmetic use.

A regimen for the long-term therapeutic treatment of rosacea. The regimen includes topically applying to the skin of a subject in need of said treatment a pharmaceutical composition. The pharmaceutical composition includes about 1% w/w to about 10% w/w benzoyl peroxide as an active ingredient, and a pharmaceutically acceptable carrier or excipient. The benzoyl peroxide is the only active ingredient in said pharmaceutical composition, and the pharmaceutical composition is applied once daily for a period of up to about 40 weeks to about 52 weeks, to achieve, in a group of such subjects, a success rate of about 75% to about 85%.

A composition for detecting blood includes 3,3′, 5, 5′-tetramethylbenzidine, cumene hydroperoxide, and a surfactant. The composition is an aqueous solution. The surfactant is an anionic surfactant or a non-ionic surfactant. The composition is useful for the detection of blood, in particular occult blood in saliva. Also described are methods for detecting blood using the composition, a kit including the composition, and the use of a surfactant to reduce the time taken to detect blood.